About SRT > Team > Dr. Michel Sadelain

Dr. Michel Sadelain

Director of the Columbia Initiative in Cell Engineering and Therapy (CICET)
Director of the Cancer Cell Therapy Initiative in the Herbert Irving Comprehensive Cancer Center (HICCC)

Immunologist Michel Sadelain studies the mechanisms governing transgene expression, stem cell engineering, and genetic strategies to enhance immunity against cancer.
MD, University of Paris
PhD, University of Alberta

Warren Alpert Foundation Prize, Harvard University (2024)
Canada Gairdner International Award (2024)
Breakthrough Prize (2023)
Clarivate Citation Laureate (2023)
American Society of Gene & Cell Therapy Outstanding Achievement Award (2021)
ASGCT Outstanding Achievement Award (2021)
Leopold Griffuel Award (2020)
INSERM International Prize (2019)
Jacob and Louise Gabbay Award in Biotechnology and Medicine (2019)
Passano Laureate and Physician Scientist Award, Johns Hopkins University (2018)
Pasteur Weizmann/Servier Prize at the Academy of Sciences in Paris (2018)
Orphan Dream Award (2018)
Inventor of the Year Award, New York Intellectual Property Law Association (NYIPLA) (2014)
Antonio Cao Award for Research in Thalassemia or Hemoglobinopathies, Palermo, Italy (2013)
Sultan Bin Khalifa International Thalassemia Award (2013)
Coley Award of the Cancer Research Institute for Distinguished Research in Tumor Immunology (2012)



+1 (312) 441-1800



United States:
100 S. Ashley Drive
Suite 600-2508
Tampa, Florida
33602

Europe:
Via Marecchia, 38
Altamura (BA)
Italy
70022